» Articles » PMID: 38139218

The Immune Response to the Myxozoan Parasite in Salmonids: A Review on Whirling Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Dec 23
PMID 38139218
Authors
Affiliations
Soon will be listed here.
Abstract

Salmonids are affected by the economically significant whirling disease (WD) caused by the myxozoan parasite . In the past, it was endemic to Eurasia, but it has now spread to different regions of North America, Europe, New Zealand, and South Africa. Among salmonids, rainbow trout is considered the most highly susceptible host. Upon entering to the host's body, the parasite invades the spine and cranium, resulting in whirling behaviour, a blackened tail, and destruction of cartilage. The disease is characterized by the infiltration of numerous inflammatory cells, primarily lymphocytes and macrophages, with the onset of fibrous tissue infiltration. Several efforts have been undertaken to investigate the role of various immune modulatory molecules and immune regulatory genes using advanced molecular methods including flow cytometry and transcriptional techniques. Investigation of the molecular and cellular responses, the role of STAT3 in Th17 cell differentiation, and the inhibitory actions of suppressors of cytokine signaling (SOCS) on interferons and interleukins, as well as the role of natural resistance-associated macrophage proteins (Nramp) in WD have significantly contributed to our understanding of the immune regulation mechanism in salmonids against . This review thoroughly highlights previous research and discusses potential future directions for understanding the molecular immune response of salmonids and the possible development of prophylactic approaches against WD.

Citing Articles

Novel insights into immune stress markers associated with myxosporeans gill infection in Nile tilapia (molecular and immunohistochemical studies).

Ramadan R, Mahdy O, El-Saied M, Mohammed F, Salem M PLoS One. 2024; 19(6):e0303702.

PMID: 38833454 PMC: 11149867. DOI: 10.1371/journal.pone.0303702.


The myxozoans and modulate rainbow trout immune responses: quantitative shotgun proteomics at the portals of entry after single and co-infections.

Saleh M, Hummel K, Schlosser S, Razzazi-Fazeli E, Bartholomew J, Holzer A Front Cell Infect Microbiol. 2024; 14:1369615.

PMID: 38803570 PMC: 11129561. DOI: 10.3389/fcimb.2024.1369615.

References
1.
Kent M, Hedrick R . Effects of cortisol implants on the PKX myxosporean causing proliferative kidney disease in rainbow trout, Salmo gairdneri. J Parasitol. 1987; 73(3):455-61. View

2.
Markkula S, Karvonen A, Salo H, Valtonen E, Jokinen E . Ultraviolet B irradiation affects resistance of rainbow trout (Oncorhynchus mykiss) against bacterium Yersinia ruckeri and trematode Diplostomum spathaceum. Photochem Photobiol. 2007; 83(5):1263-9. DOI: 10.1111/j.1751-1097.2007.00165.x. View

3.
Avila B, Winkelman D, Fetherman E . Survival of Whirling-Disease-Resistant Rainbow Trout Fry in the Wild: A Comparison of Two Strains. J Aquat Anim Health. 2018; 30(4):280-290. DOI: 10.1002/aah.10040. View

4.
Sarker S, Menanteau-Ledouble S, Kotob M, El-Matbouli M . A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo. PLoS One. 2017; 12(6):e0178687. PMC: 5456292. DOI: 10.1371/journal.pone.0178687. View

5.
Turner K, Smith M, Ridenhour B . Whirling disease dynamics: an analysis of intervention strategies. Prev Vet Med. 2014; 113(4):457-68. DOI: 10.1016/j.prevetmed.2013.12.008. View